Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Detail of > 81156-93-6

  • CAS Number:
  • 81156-93-6
  • Name:
  • Glycine,L-arginyl-L-arginyl-L-leucyl-L-isoleucyl-L-a-glutamyl-L-a-aspartyl-L-alanyl-L-a-glutamyl-L-tyrosyl-L-alanyl-L-alanyl-L-arginyl-

  • Formula:
  • C64H106 N22 O21
  • Molecular Structure:
  • Synonyms:
  • 101:PN: FR2862981 SEQID: 101 unclaimed sequence; 101: PN: WO2004033476 SEQID: 101unclaimed sequence; 11: PN: WO2006094704 SEQID: 1 unclaimed sequence; 124: PN:US20030119021 SEQID: 121 unclaimed sequence; 12: PN: CA2504920 SEQID: 12 unclaimedsequence; 12: PN: US20060134693 SEQID: 12 unclaimed sequence; 13: PN:WO2009149577 PAGE: 25 unclaimed sequence; 14: PN: WO03082907 SEQID: 14unclaimed sequence; 15: PN: CA2589393 SEQID: 6 unclaimed sequence; 168: PN:WO2004069191 PAGE: 75 unclaimed sequence; 16: PN: US20030108986 SEQID: 29unclaimed sequence; 190: PN: US20070037134 SEQID: 209 unclaimed sequence; 1:PN: US20030072738 PAGE: 8 unclaimed sequence; 1: PN: WO2007084631 PAGE: 28unclaimed sequence; 27: PN: US20050100951 SEQID: 37 unclaimed sequence; 3: PN:US20030161893 SEQID: 3 unclaimed sequence; 3: PN: US20050215629 SEQID: 3unclaimed sequence; 40: PN: US20050037343 SEQID: 37 unclaimed sequence; 4: PN:US6335176 SEQID: 5 unclaimed sequence; 4: PN: WO03057730 SEQID: 4 unclaimedsequence; 5: PN: WO0017329 SEQID: 7 unclaimed sequence; 5: PN: WO02077153SEQID: 5 unclaimed sequence; 74: PN: US20040086966 SEQID: 74 unclaimed protein;74: PN: US20050155090 SEQID: 74 unclaimed sequence; 74: PN: US20070213508SEQID: 74 unclaimed sequence; 74: PN: US20070213510 SEQID: 74 unclaimedsequence; 74: PN: US20070238862 SEQID: 74 unclaimed sequence; 7: PN:US20040010045 SEQID: 7 unclaimed sequence; 7: PN: WO03092616 SEQID: 7 unclaimedsequence; Peptide RRsrc (synthetic tyrosine protein kinase substrate); RR-SRC;Src-Peptide
  • Molecular Weight:
  • 1519.68
  • Solubility:
  • H2O: soluble
  • Appearance:
  • lyophilized powder
  • Safety:
  • 22-24/25Details
Home > Products > 81156-93-6

Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!

Supplier Location:
United States(1)
Business Type:
Importer/Exporter(1)
Certificates:
ISO (0) Production License (0)

Page:1/1   

CAS No. 

81156-93-6 ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY

more information,pls contact with us!
United States  
  • Tel:(815) 968-0747
  • Address:PO Box 117, Rockford, IL 61105 USA
  • Total:1 Page 1 of 1 1
  • Please post your buying leads,so that our qualified suppliers will soon contact you!
    *Required Fields

    Reference

    Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor
    Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. Wedegaertner, Philip B.; Gill, Gordon N. (Dep. Chem., Univ. California, San Diego, La Jolla, CA 92093-0650, USA). Arch. Biochem. Biophys., 292(1), 273-80 (English) 1992.In this article, certain chemicals are used. Some of their cas registry numbers are 139123-04-9 and 81156-93-6 CODEN: ABBIA4. ISSN: 0003-9861. DOCUMENT TYPE: Journal CA Section: 7 (Enzymes) Section cross-reference(s): 2 The carboxyl terminal domain of the epidermal growth factor receptor (EGFR) is an important regulatory region in mediating the tyrosine kinase-dependent biol. effects of EGF. The effect of a 164-amino-acid carboxyl deletion of the EGFR or the EGFR cytoplasmic kinase domain on in vitro tyrosine kinase activity was assessed. C'-terminal truncation of the EGFR resulted in dependence on Mn2+ for full activity. The EGFR kinase domain (kd EGFR) and the C'-terminally truncated kinase domain (kd c'1022 EGFR) also exhibited a strong preference for Mn2+ compared to Mg2+, with kd c'1022 EGFR being completely inactive in the presence of Mg2+ alone. Sphingosine or ammonium sulfate specifically activated both kd EGFR and kd c'1022 EGFR. EGFR and c'1022 EGFR displayed similar EGF-stimulated in vitro tyrosine kinase activities; however, kd EGFR was 5- to 10-fold more active in vitro than kd c'1022 EGFR. Thus, the regulatory contribution of the C'-terminus is most evident when the EGFR ligand binding domain is removed. These results indicate that an intact EGFR C'-terminus is necessary for the protein to assume a fully active conformation. .

    ©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

    [Hangzhou]86-571-85317600,85317603,85317620